330 related articles for article (PubMed ID: 16034947)
1. Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV.
Chang LW; Phipps WT; Kennedy GE; Rutherford GW
Cochrane Database Syst Rev; 2005 Jul; (3):CD004773. PubMed ID: 16034947
[TBL] [Abstract][Full Text] [Related]
2. Primary antifungal prophylaxis for cryptococcal disease in HIV-positive people.
Awotiwon AA; Johnson S; Rutherford GW; Meintjes G; Eshun-Wilson I
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD004773. PubMed ID: 30156270
[TBL] [Abstract][Full Text] [Related]
3. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
Pienaar ED; Young T; Holmes H
Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
[TBL] [Abstract][Full Text] [Related]
4. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
Pienaar ED; Young T; Holmes H
Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD003940. PubMed ID: 21069679
[TBL] [Abstract][Full Text] [Related]
5. Treatment for HIV-associated cryptococcal meningitis.
Tenforde MW; Shapiro AE; Rouse B; Jarvis JN; Li T; Eshun-Wilson I; Ford N
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD005647. PubMed ID: 30045416
[TBL] [Abstract][Full Text] [Related]
6. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
Eshun-Wilson I; Okwen MP; Richardson M; Bicanic T
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009012. PubMed ID: 30039850
[TBL] [Abstract][Full Text] [Related]
7. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.
Ray A; Ray S; George AT; Swaminathan N
Cochrane Database Syst Rev; 2011 Aug; (8):CD008739. PubMed ID: 21833970
[TBL] [Abstract][Full Text] [Related]
8. Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis.
Njei B; Kongnyuy EJ; Kumar S; Okwen MP; Sankar MJ; Mbuagbaw L
Cochrane Database Syst Rev; 2013 Feb; (2):CD009012. PubMed ID: 23450595
[TBL] [Abstract][Full Text] [Related]
9. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.
Ng BE; Butler LM; Horvath T; Rutherford GW
Cochrane Database Syst Rev; 2011 Mar; (3):CD001220. PubMed ID: 21412869
[TBL] [Abstract][Full Text] [Related]
10. Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial.
Parkes-Ratanshi R; Wakeham K; Levin J; Namusoke D; Whitworth J; Coutinho A; Mugisha NK; Grosskurth H; Kamali A; Lalloo DG;
Lancet Infect Dis; 2011 Dec; 11(12):933-41. PubMed ID: 21982529
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Sloan D; Dlamini S; Paul N; Dedicoat M
Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
13. Current approach to the acute management of cryptococcal infections.
Powderly WG
J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
[No Abstract] [Full Text] [Related]
14. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
Playford EG; Webster AC; Sorell TC; Craig JC
Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
[TBL] [Abstract][Full Text] [Related]
15. Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome.
Zeind CS; Cleveland KO; Menon M; Brown JR; Solomon DK
Pharmacotherapy; 1996; 16(4):547-61. PubMed ID: 8840361
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia.
Micol R; Tajahmady A; Lortholary O; Balkan S; Quillet C; Dousset JP; Chanroeun H; Madec Y; Fontanet A; Yazdanpanah Y
PLoS One; 2010 Nov; 5(11):e13856. PubMed ID: 21085478
[TBL] [Abstract][Full Text] [Related]
17. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis.
Li Y; Huang X; Chen H; Qin Y; Hou J; Li A; Wu H; Yan X; Chen Y
BMC Infect Dis; 2020 Jun; 20(1):410. PubMed ID: 32532212
[TBL] [Abstract][Full Text] [Related]
19. The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection.
Nelson MR; Fisher M; Cartledge J; Rogers T; Gazzard BG
AIDS; 1994 May; 8(5):651-4. PubMed ID: 8060545
[TBL] [Abstract][Full Text] [Related]
20. Progressive resistive exercise interventions for adults living with HIV/AIDS.
O'Brien K; Nixon S; Glazier RH; Tynan AM
Cochrane Database Syst Rev; 2004 Oct; (4):CD004248. PubMed ID: 15495092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]